Download PDF
veterinär spiegel 2010; 20(02): 91-94
DOI: 10.1055/s-0030-1249946
Nutztiere & Pferde
Enke Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart

Infektionen mit den equinen Herpesviren vom Typ 1 und 4

Nikolaus Osterrieder
Further Information

Publication History

Publication Date:
17 June 2010 (online)

Also available at
    Permissions and Reprints All articles of this category
Zoom Image
© Corel Stock

Infektionen mit EHV-1 und EHV-4 zählen zu den wichtigsten viralen Pferdekrankheiten. Während EHV-1 regelmäßig systemische Infektionen verursacht und neben meist milden respiratorischen Erkrankungen auch häufiger zu Aborten trächtiger Tiere und zur herpesviralen Enzephalomyelopathie führt, bleibt EHV-4 in der Regel auf den Respirationstrakt beschränkt. Der Nachweis gelingt im Nasensekret mittels Virusanzucht oder Nachweis der viralen DNA durch PCR-Verfahren. Zur serologischen Diagnose wird zumeist der Serumneutralisationstest eingesetzt, der jedoch keine Differenzierung von EHV-1- und EHV-4-Infektion erlaubt. Ein Serumpaar ist geeignet, eine kürzlich stattgehabte Infektion zu diagnostizieren.

 

  • Literatur

  • 1 Allen G, Yeargan M, Costa LR, Cross R. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J Virol 1995; 69: 606-612
    Google Scholar
  • 2 Allen GP, Bryans JT. Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Prog Vet Microbiol Immunol 1986; 2: 78-144
    Google Scholar
  • 3 Allen GP, Bolin DC, Bryant U, Carter CN, Giles RC, Harrison LR, Hong CB, Jackson CB, Poonacha K, Wharton R, Williams NM. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the thoroughbred broodmare population of central Kentucky. Equine Vet J 2008; 40: 105-110
    Google Scholar
  • 4 Breathnach CC, Yeargan MR, Sheoran AS, Allen GP. The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens. Equine Vet J 2001; 33: 651-657
    Google Scholar
  • 5 Crabb BS, MacPherson CM, Reubel GH, Browning GF, Studdert MJ, Drummer HE. A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1. Arch Virol 1995; 140: 245-258
    Google Scholar
  • 6 Foote CE, Love DN, Gilkerson JR, Whalley JM. Serological responses of mares and weanlings following vaccination with an inactivated whole virus equine herpesvirus 1 and equine herpesvirus 4 vaccine. Vet Microbiol 2002; 88: 13-25
    Google Scholar
  • 7 Foote CE, Love DN, Gilkerson JR, Whalley JM. Detection of EHV-1 and EHV-4 DNA in unweaned thoroughbred foals from vaccinated mares on a large stud farm. Equine Vet J 2004; 36: 341-345
    Google Scholar
  • 8 Goodman LB, Wagner B, Flaminio MJ, Sussman KH, Metzger SM, Holland R, Osterrieder N. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1). Vaccine 2006; 24: 3636-3645
    Google Scholar
  • 9 Goodman LB, Loregian A, Perkins GA, Nugent J, Buckles EL, Mercorelli B, Kydd JH, Palu G, Smith KC, Osterrieder N, Davis-Poynter N. A point mutation in a herpesvirus polymerase determines neuropathogenicity. PLoS Pathog 2007; 3: e160
    Google Scholar
  • 10 Hubert PH, Birkenmaier S, Rziha HJ, Osterrieder N. Alterations in the equine herpesvirus type-1 (EHV-1) strain RacH during attenuation. Zentralbl Veterinarmed [B] 1996; 43: 1-14
    Google Scholar
  • 11 Lunn DP, Davis-Poynter N, Flaminio MJ, Horohov DW, Osterrieder K, Pusterla N, Townsend HG. Equine herpesvirus-1 consensus statement. J Vet Intern Med 2009; 23: 450-461
    Google Scholar
  • 12 Mumford JA, Rossdale PD, Jessett DM, Gann SJ, Ousey J, Cook RF. Serological and virological investigations of an equid herpesvirus 1 (EHV-1) abortion storm on a stud farm in 1985. J Reprod Fertil Suppl 1987; 35: 509-518
    Google Scholar
  • 13 Osterrieder N, de Walle GR Van. Pathogenic potential of equine alphaherpesviruses: The importance of the mononuclear cell compartment in disease outcome. Vet Microbiol 2010; (im Druck)
    Google Scholar
  • 14 Osterrieder N, Neubauer A, Brandmuller C, Kaaden OR, O'Callaghan DJ. The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence. Virology 1996; 226: 243-251
    Google Scholar
  • 15 Paillot R, Daly JM, Juillard V, Minke JM, Hannant D, Kydd JH. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1. Vaccine 2005; 23: 4541-4551
    Google Scholar
  • 16 Patel JR, Bateman H, Williams J, Didlick S. Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1. Vet Microbiol 2003; 91: 23-39
    Google Scholar
  • 17 Patel JR, Didlick S, Bateman H. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection. Equine Vet J 2004; 36: 447-451
    Google Scholar
  • 18 Patel JR, Heldens J. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4) – epidemiology, disease and immunoprophylaxis: a brief review. Vet J 2005; 170: 14-23
    Google Scholar
  • 19 Perkins GA, Goodman LB, Dubovi EJ, Kim SG, Osterrieder N. Detection of equine herpesvirus-1 in nasal swabs of horses by quantitative real-time PCR. J Vet Intern Med 2008; 22: 1234-1238
    Google Scholar
  • 20 Pusterla N, Leutenegger CM, Wilson WD, Watson JL, Ferraro GL, Madigan JE. Equine herpesvirus-4 kinetics in peripheral blood leukocytes and nasopharyngeal secretions in foals using quantitative real-time TaqMan PCR. J Vet Diagn Invest 2005; 17: 578-581
    Google Scholar
  • 21 Pusterla N, Hussey SB, Mapes S, Leutenegger CM, Madigan JE, Ferraro GL, Wilson WD, Lunn DP. Comparison of four methods to quantify equid herpesvirus 1 load by real-time polymerase chain reaction in nasal secretions of experimentally and naturally infected horses. J Vet Diagn Invest 2009; 21: 836-840
    Google Scholar
  • 22 Rosas CT, Goodman LB, Einem J von, Osterrieder N. Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?. Expert Rev Vaccines 2006; 5: 119-131
    Google Scholar
  • 23 Slater JD, Lunn DP, Horohov DW, Antczak DF, Babiuk L, Breathnach C, Chang YW, Davis-Poynter N, Edington N, Ellis S, Foote C, Goehring L, Kohn CW, Kydd J, Matsumura T, Minke J, Morley P, Mumford J, Neubauer T, O'Callaghan D, Osterrieder K, Reed S, Smith K, Townsend H, der Meulen K van, Whalley M, Wilson WD. Report of the equine herpesvirus-1 Havermeyer Workshop, San Gimignano, Tuscany, June 2004. Vet Immunol Immunopathol 2006; 111: 3-13
    Google Scholar
  • 24 Smith KC, Mumford JA, Lakhani K. A comparison of equid herpesvirus-1 (EHV-1) vascular lesions in the early versus late pregnant equine uterus. J Comp Pathol 1996; 114: 231-247
    Google Scholar
  • 25 Smith KC, Borchers K. A study of the pathogenesis of equid herpesvirus-1 (EHV-1) abortion by DNA in-situ hybridization. J Comp Pathol 2001; 125: 304-310
    Google Scholar
  • 26 Tearle JP, Smith KC, Platt AJ, Hannant D, Davis-Poynter NJ, Mumford JA. In vitro characterisation of high and low virulence isolates of equine herpesvirus-1 and − 4. Res Vet Sci 2003; 75: 83-86
    Google Scholar
  • 27 Telford EA, Watson MS, Perry J, Cullinane AA, Davison AJ. The DNA sequence of equine herpesvirus-4. J Gen Virol 1998; , 79 (Pt 5) 1197-1203
    Google Scholar
  • 28 University of Kentucky, Gluck Equine Research Center Diseases of the horse caused by equine herpesvirus type 1 (EHV-1) – a bibliography of source materials. Im Internet:. http://www.ca.uky.edu/gluck/images/info%2520pages/ehv1/ehv5703Large.jpg Stand: 10.05.2010
    Google Scholar